Labcorp Q1 Revenue Up 5.8% to $3.54B, Lifts Full-Year EPS Guidance
LH•Labcorp reported Q1 net income of $277.8 million, diluted EPS of $3.35 and adjusted EPS of $4.25 on revenue of $3.54 billion, up 5.8% with adjusted EPS up 10.6% year-over-year. The company raised full-year adjusted EPS guidance by $0.13 to a range of $17.70–$18.35.
1. First-Quarter Financial Performance
Labcorp generated net income of $277.8 million in Q1, corresponding to diluted EPS of $3.35 and adjusted EPS of $4.25 on revenues of $3.54 billion. Revenue rose 5.8% year-over-year while adjusted EPS increased 10.6%, driven by strength in Diagnostics and Central Laboratory services.
2. Raised Full-Year Guidance
Following stronger-than-expected Q1 results, Labcorp raised its full-year adjusted EPS guidance by $0.13 at the midpoint to a range of $17.70–$18.35 per share. Revenue guidance was maintained at growth of 5.0%–6.1%, reflecting confidence in ongoing organic expansion and acquisitions.
3. Strategic Collaborations and Capital Allocation
Labcorp advanced specialty and companion diagnostics partnerships, including a nationwide collaboration with a major pediatric hospital and an alliance with Optum.ai to enhance lab operations via AI. In Q1, the company invested $202.2 million in acquisitions, repurchased $98.0 million of stock, paid $61.2 million in dividends and declared a $0.72 quarterly payout.
